Malta since 2010  

                      Introducing Pharmacare Premium

                                

Malta’s Pharmacare Premium (PCM), an elite subsidiary of Pharmacare specialises in an Oncology (Anti-Cancer) therapeutic ‘high-potency’ product line state-of-the-art, in addition to producing conventional products primarily aimed at markets in Europe and MENA, and the repackaging PRP products and distributing to EU countries. Pharmacare Premium acquired the EU c-GMP approval in 2011, and has since been a certified facility to start operating as a batch release site. PCM comprises a 100% PCE-owned company based in Hal-Far, Malta, and is represented by the Pharmacare PLC CEO, Dr B Khoury.

 

Copy ©2024 PharmaCare, All Rights Reserved